- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02127229
Cost Analysis for Endoscopic Retrograde Cholangiopancreatography (ERCP) (ERCP)
The Impact of Cost Itemization on Resource Utilization With ERCP
The purpose of the study is to determine if endoscopist notification of accessory cost results in altered resource utilization related to the total cost and number of accessories used in ERCP.
This study will be a prospective cost--analysis study. Only chart review of PHI removed records will be used. The only intervention used is that endoscopists will be made aware of the cost of accessories used in the second phase of the study following each ERCP.
The investigators are in an era of increased medical cost consciousness. Medical education and post--graduate education incorporates cost savings and appropriate diagnostic test selection based on expense as one aspects of the decision process. This era now focuses on what is best for the patient with the understanding that the cost to the patient and cost to the overall health care system matters. Not only is this apart of postgraduate training but now being implemented as part of Medicare reimbursement to provide low cost and high quality care. Incidence of pancreatic and biliary disease is increasing. ERCP is a vital tool for therapeutic intervention. The costs of these procedures, to both patients and hospitals, have caused some to question the amount of accessories used as well as the poor reimbursement provided by Medicare and insurers. Studies have indicated that hospitals actually lose money with each ERCP used and their use is being limited many times to tertiary care centers.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study is a prospective cost-identification analysis of accessories used during the ERCP. The study will be conducted in two phases. Each phase will include at least 71 ERCP procedures. All consecutive patients undergoing ERCP will be included. For the first phase of the study the physicians performing the procedure will not be made aware of the study and also will not be briefed at the end of the procedure with the number of accessories used during the procedure and the dollar value of the accessories. For the second phase of the study, endoscopist will be briefed by the endoscopy manager after completion of each procedure about the total number of accessories used and the dollar value of the accessories used during the procedure.
During the study period, all gathered information will be deidentified but the procedure indication and whether it was successful or not will be collected. Only deidentified information will be collected. Endoscopists will not be aware of the study to avoid a Hawthorne effect. The endoscopists resource utilization is what is being studied. They will be debriefed at completion of protocol.
ERCP's requiring cholangioscopy (spyglass), stent removal alone, or just stent exchange will be excluded from the cost analysis, because of the atypical nature of the procedures and the number of accessories used during these procedures may not reflect the number of accessories used during a typical procedure. For both groups, if an endoscopic ultrasound is used for gaining biliary access it will be included in the cost analysis of this study. Both outpatient and inpatients will be included for both groups. All investigator patients will be excluded from the analysis.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73104
- University of Oklahoma Health Science Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult receiving ERCP at Endoscopy diagnostic center.
Exclusion Criteria:
- No stent removal or replacement procedures. EUS can only be used for intubation of bile duct. No spyglass will added to total cost.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Blinded observation of ERCP
Blind observation of disposable accessories use.
|
|
|
Experimental: Endoscopist informed of cost per procedure
Endoscopists informed following each ERCP.
|
Following each procedure, endoscopists will get a cost report regarding the amount spent on disposable accessories.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reduction of total cost of disposable accessories used for individual ERCP procedures
Time Frame: ERCP procedures will be observed for up to 3 months for each arms of study
|
Two arms in the study.
One arm is observation of blinding endoscopists and calculating cost of disposable accessories used while performing ERCP.
The other arm will be the intervention group.
Before the intervention period begins, advanced endoscopists will be informed that there cost is being monitored for each ERCP and the cost of disposable accessories.
Following each ERCP during the intervention group, the endoscopists will be informed of the cost of that individual procedure based on disposable accessories.
|
ERCP procedures will be observed for up to 3 months for each arms of study
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cost identification of disposable accessory use in ERCP
Time Frame: ERCP procedures will be observed for up to 3 months for each arms of study
|
Two arms in the study.
One arm is observation of blinding endoscopists and calculating cost of disposable accessories used while performing ERCP.
The other arm will be the intervention group.
Before the intervention period begins, advanced endoscopists will be informed that there cost is being monitored for each ERCP and the cost of disposable accessories.
Following each ERCP during the intervention group, the endoscopists will be informed of the cost of that individual procedure based on disposable accessories.
|
ERCP procedures will be observed for up to 3 months for each arms of study
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 574462
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Biliary Obstruction
-
Chung-Ang University Hosptial, Chung-Ang University...OSYMED CO., Ltd.Not yet recruitingMalignant Biliary Obstruction | Biliary Obstruction | Malignant Distal Biliary Obstruction
-
Kafrelsheikh UniversityCompletedBiliary ObstructionEgypt
-
Military Medical Clinical Center of the Southern...CompletedCholedocholithiasis | Malignant Biliary Obstruction | Biliary Obstruction | Gallstone Disease | Benign Biliary Strictures With Current or Prior Biliary Obstruction | Papillary Stenosis | External Biliary FistulaUkraine
-
University of AlexandriaCompletedPeriampullary Cancer | Biliary Obstruction | Preoperative Biliary Drainage
-
National Taiwan University HospitalShin Kong Wu Ho-Su Memorial Hospital; China Medical University Hospital; Chang... and other collaboratorsRecruiting
-
Istituto Clinico HumanitasRecruiting
-
Istituto Clinico HumanitasRecruiting
-
Chinese University of Hong KongNot yet recruiting
-
Seoul National University HospitalRecruitingMalignant Biliary ObstructionKorea, Republic of
-
Boston Scientific CorporationWithdrawn
Clinical Trials on Endoscopist informed of cost per procedure
-
Plovdiv Medical UniversityCompletedCaries, DentalBulgaria
-
The Cleveland ClinicMerck Sharp & Dohme LLCRecruitingNeuromuscular BlocksUnited States
-
University Hospital, ToulouseRecruitingCerebrovascular AccidentFrance
-
University of MiamiCompletedLung Cancer | Non Small Cell Lung Carcinoma | HypermethylationUnited States
-
Dalia Salah SaifUnknown
-
Selcuk UniversityCompletedNasopharyngeal Diseases
-
Bristol-Myers SquibbCompleted
-
Yazeed SawalhaAbbVie; GenmabRecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Transformed Non-Hodgkin Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Acute Myeloid Leukemia Post Cytotoxic TherapyUnited States
-
Children's Oncology GroupNot yet recruitingT Acute Lymphoblastic Leukemia | T Lymphoblastic Lymphoma | Stage II T Lymphoblastic Leukemia/Lymphoma | Stage III T Lymphoblastic Leukemia/Lymphoma | Stage IV T Lymphoblastic Leukemia/Lymphoma